Hormonal Contraceptive Eligibility for Women at High Risk of HIV Guidance Statement

Hormonal Contraceptive Eligibility for Women at High Risk of HIV The World Health Organization (WHO) convened a technical consultation during 1–2 December 2016 to review new evidence on the risk of HIV acquisition with the use of hormonal contraception. The issue was...

Webinar: Hormonal Contraception and HIV: Putting New Developments in Context

Webinar: Hormonal Contraception and HIV: Putting New Developments in Context Panelists Dr. Mike Chirenje, University of Zimbabwe, Bergen Cooper, CHANGE, Dazon Dixon Diallo, Sisterlove and Lillian Mworeko, International Community of Women Living with HIV, East Africa...

Map: Provision of Injectable Contraceptives by Community Health Workers

Map: Provision of Injectable Contraceptives by Community Health Workers A map that illustrates the status of the provision of injectable contraceptives by community health workers by country in sub-Saharan Africa (SSA).       Published: 2017 Source:...

ECHO Management Committee on New WHO Guidance on Use of Hormonal Contraceptives by Women at High Risk of HIV

ECHO Management Committee on New WHO Guidance on Use of Hormonal Contraceptives by Women at High Risk of HIV Statement by the ECHO Management Committee on the new WHO guidance on use of hormonal contraceptives by women at high risk of HIV.       ...

ECHO Trial Protocol

ECHO Trial Protocol Protocol for “A Multi Center, Open-Label, Randomised Clinical Trial Comparing HIV Incidence and Contraceptive Benefits in Women using Depot Medroxyprogesterone Acetate (DMPA), Levonorgestrel (LNG) Implant, and Copper Intrauterine Devices...